Barcelona Alzheimer Treatment & Research Center

Posts Tagged 2014

Methylglyoxal Produced by Amyloid-β Peptide-Induced Nitrotyrosination of Triosephosphate Isomerase Triggers Neuronal Death in Alzheimer’s Disease.

Methylglyoxal Produced by Amyloid-β Peptide-Induced Nitrotyrosination of Triosephosphate Isomerase Triggers Neuronal Death in Alzheimer’s Disease. Tajes M, Eraso-Pichot A, Rubio-Moscardó F, Guivernau B, Ramos-Fernández E, Bosch-Morató M, Guix FX, Clarimón J, Miscione GP, Boada M, Gil-Gómez G, Suzuki T, Molina H, Villà-Freixa J, Vicente R, Muñoz FJ. J Alzheimers Dis. 2014






Valoración de las funciones visuoperceptivas yvisuoespaciales en la práctica forense.

Valoración de las funciones visuoperceptivas yvisuoespaciales en la práctica forense. Ortega G, Alegret M, Espinosa A, Ibarria M, Cañabate P, Boada M. Rev Esp Med Legal. 2014;40:83-5. PDF






Approaching allelic probabilities and Genome-Wide Association Studies from beta distributions.

Approaching allelic probabilities and Genome-Wide Association Studies from beta distributions. J. Santiago García-Cremades, Ángel del Río, José A. García, Javier Gayán, Antonio González-Pérez, Agustín Ruiz,Oscar Sotolongo-Grau, Manuel Ruiz-Marín. arXiv:1402.6151 [q-bio.GN] 25 feb 2014. PDF






Follow up of loci from the International Genomics of Alzheimer’s Disease Project identifies TRIP4 as a novel susceptibility gene.

Follow up of loci from the International Genomics of Alzheimer’s Disease Project identifies TRIP4 as a novel susceptibility gene. Ruiz A, Heilmann S, Becker T, Hernández I, Wagner H, Thelen M, Mauleón A,Rosende-Roca M, Bellenguez C, Bis JC, Harold D, Gerrish A, Sims R, Sotolongo-Grau O, Espinosa A, Alegret M, Arrieta JL, Lacour A, Leber M, Becker






Posttranslational Nitro-Glycative Modifications of Albumin in Alzheimer’s Disease: Implications in Cytotoxicity and Amyloid-β Peptide Aggregation.

Posttranslational Nitro-Glycative Modifications of Albumin in Alzheimer’s Disease: Implications in Cytotoxicity and Amyloid-β Peptide Aggregation. Ramos-Fernández E, Tajes M, Palomer E, Ill-Raga G, Bosch-Morató M, Guivernau B, Román-Dégano I, Eraso-Pichot A, Alcolea D, Fortea J, Nuñez L, Paez A, Alameda F, Fernández-Busquets X, Lleó A, Elosúa R, Boada M,






ATP5H/KCTD2 locus is associated with Alzheimer’s disease risk.

ATP5H/KCTD2 locus is associated with Alzheimer’s disease risk. Boada M, Antúnez C, Ramírez-Lorca R, Destefano AL, González-Pérez A, Gayán J, López-Arrieta J, Ikram MA, Hernández I, Marín J, Galán JJ, Bis JC,Mauleón A, Rosende-Roca M, Moreno-Rey C, Gudnasson V, Morón FJ, Velasco J, Carrasco JM, Alegret M,Espinosa A, Vinyes G, Lafuente A, Vargas L,






Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation.

Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation. Suárez-Calvet M, Dols-Icardo O, Lladó A, Sánchez-Valle R,Hernández I, Amer G, Antón-Aguirre S, Alcolea D, Fortea J, Ferrer I, van der Zee J, Dillen L, Van Broeckhoven C,






Design of a comprehensive Alzheimer’s disease clinic and research center in Spain to meet critical patient and family needs.

Design of a comprehensive Alzheimer’s disease clinic and research center in Spain to meet critical patient and family needs. Boada M, Tárraga L, Hernández I, Valero S, Alegret M, Ruiz A, Lopez OL, Becker JT; Fundació ACE Alzheimer Research Center and Memory Clinic. Alzheimers Dement. 2014 May;10(3):409-15.PDF






Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia.

Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia. Dols-Icardo O, García-Redondo A, Rojas-García R, Sánchez-Valle R, Noguera A, Gómez-Tortosa E, Pastor P, Hernández I, Esteban-Pérez J, Suárez-Calvet M, Antón-Aguirre S, Amer G, Ortega-Cubero S, Blesa R, Fortea J, Alcolea D, Capdevila A,






Assessing the Role of the Trem2 P.R47h Variant as a Risk Factor for Alzheimer’s Disease and Frontotemporal Dementia.

Assessing the Role of the Trem2 P.R47h Variant as a Risk Factor for Alzheimer’s Disease and Frontotemporal Dementia. Ruiz A, Dols-Icardo O, Bullido MJ, Pastor P, Rodríguez-Rodríguez E, López de Munain A, de Pancorbo MM, Pérez-Tur J, Alvarez V, Antonell A, López-Arrieta J, Hernández I, Tárraga L,Boada M, Lleó A, Blesa R, Frank-García






Página 3 de 41234